Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 263.75
+4.15 (1.60%)
Sep 9, 2025, 3:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 32.45 billion as of September 9, 2025. Its market cap has decreased by -21.34% in one year.
Market Cap
32.45B
Enterprise Value
39.92B
Revenue
18.33B
Ranking
n/a
PE Ratio
51.27
Stock Price
263.75
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 32.45B, an increase of 2,291.14%. That is a compound annual growth rate of 14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 32.45B | -32.51% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | 20.31B | 44.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,793.35B |
| Divi's Laboratories | 1,600.11B |
| Cipla | 1,244.91B |
| Apollo Hospitals Enterprise | 1,119.58B |
| Mankind Pharma | 1,064.67B |
| Zydus Lifesciences | 1,015.94B |
| Fortis Healthcare | 711.85B |
| Alkem Laboratories | 637.64B |